Quote:
Originally Posted by Hugh
No, it's a rebuttal of "it's been there 20 years", as if there were only UK funding for the company - the EU helped fund the research which made the production possible.
I don't think the EU has any claim on the O/AZ vaccines produced in the UK, but the denial of the facts that EU put some funding into the process is not accurate.
---------- Post added at 21:21 ---------- Previous post was at 21:19 ----------
Been there, done that - worst case if Execs & Sales go in, and won't have a meeting before hand with Production to agree a script/limits/things not to promise (and apparently, screaming "WTAF are you doing - that's impossible" is frowned upon by Senior Management in client meetings  ). |
As I pointed out, not only was the article from spring 2015, it mentions various collaborations with UK universities and funding from UKs Department of Trade and Industry. The article talks about research into administering vaccines orally. How is that connected to anything?
The way EU funding worked for the UK was that 66% of any money that came back to the UK, was taken off the rebate. Therefore well over 66% of the EU money actually came from the UK. Eg if the EU spent 3m Euros in the UK, 2m of that would be knocked off the rebate and be extra money the UK had to pay.
Anything that the EU is supposed to have funded, is completely unrelated to Covid.
The EU will still have the Pfizer vaccine...
Quote:
Croda, Snaith
The East Yorkshire headquartered smart science specialist is supplying an ingredient used in the Pfizer BioNtech Covid-19 vaccine.
The carrier is used to transport the vaccine's active element into the body.
It is produced at sites in the UK and US.
|
But not if they blockade the UK.